Cspc Pharmaceutical dividend calculator – CSPC Pharmaceutical Group Ltd Announces 0.11 Cash Dividend
June 12, 2023
🌥️Dividends Yield
CSPC ($BER:CVG) Pharmaceutical Group Ltd has announced a cash dividend of 0.11 CNY per share on June 1, 2023. This makes CSPC a viable option for investors looking for dividend stocks. In the past three years, CSPC has issued an annual dividend of 0.18 CNY in 2021 and 0.18 CNY in 2022 and 0.14 CNY in 2023.
This equates to yield of 2.53%, 2.53%, and 1.78% over the past three years respectively, with an average dividend yield of 2.28%. The ex-dividend date for the dividend is June 5 2023, so investors must purchase the shares by this date to be eligible for the dividends.
Price History
The stock opened at €0.8 and closed at €0.8, down by 0.1% from the previous closing price of 0.8. Despite the slight decrease in share price, the company expressed confidence in the value of their stock and their ability to provide returns to shareholders. In addition, CSPC Pharmaceutical Group Ltd also proudly announced that they are continuing to invest in brands and technologies that will benefit their customers. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Cspc Pharmaceutical. More…
| Total Revenues | Net Income | Net Margin |
| 31.12k | 6.12k | 19.5% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Cspc Pharmaceutical. More…
| Operations | Investing | Financing |
| 7.63k | -6.8k | -1.9k |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Cspc Pharmaceutical. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 38.84k | 9.42k | 2.35 |
Key Ratios Snapshot
Some of the financial key ratios for Cspc Pharmaceutical are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 11.9% | 13.7% | 24.5% |
| FCF Margin | ROE | ROA |
| 15.8% | 17.0% | 12.3% |
Analysis – Cspc Pharmaceutical Intrinsic Value Calculator
At GoodWhale, we have completed a comprehensive analysis of CSPC PHARMACEUTICAL‘s fundamentals. Our proprietary Valuation Line has determined that the fair value of CSPC PHARMACEUTICAL shares is around €1.2. Right now, the stock is trading at a price of €0.8, undervalued by 33.3%. This presents a great opportunity for investors to buy the stock at a discount and benefit from its future potential. More…
Summary
CSPC Pharmaceutical is an interesting dividend stock for investors seeking income. The company has consistently paid dividends over the last three years, with a yield of 2.28% on average. Analysis of the stock reveals a positive outlook due to its steady income and potential to increase yields in the future. Investors should take into account the company’s financials, including its debt levels, cash flow, and return on equity.
Its current dividend yield and payout ratio are both favorable, indicating that the company is in a position to continue to pay out attractive dividends. CSPC Pharmaceutical therefore presents a compelling investment opportunity for shareholders seeking regular income from their investments.
Related Posts
Recent Posts
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
